tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CMPX Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
4d ago
ABVC
CMPX
Compass Therapeutics price target raised to $24 from $10 at H.C. Wainwright
PremiumThe Fly
Compass Therapeutics price target raised to $24 from $10 at H.C. Wainwright
4d ago
CMPX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5d ago
APRE
BCDA
Compass Therapeutics upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Compass Therapeutics upgraded to Outperform from Market Perform at Leerink
6d ago
CMPX
Positive Buy Rating for Tovecimig-Paclitaxel Combo Following Promising COMPANION-002 Trial Results
PremiumRatings
Positive Buy Rating for Tovecimig-Paclitaxel Combo Following Promising COMPANION-002 Trial Results
6d ago
CMPX
Compass Therapeutics price target raised to $11 from $10 at Stifel
PremiumThe FlyCompass Therapeutics price target raised to $11 from $10 at Stifel
7d ago
CMPX
Compass Therapeutics Reports Positive Phase 2/3 Trial Results
Premium
Company Announcements
Compass Therapeutics Reports Positive Phase 2/3 Trial Results
7d ago
8K
CMPX
Compass Therapeutics says tovecimig meets primary endpoint in Phase 2/3 study
Premium
The Fly
Compass Therapeutics says tovecimig meets primary endpoint in Phase 2/3 study
7d ago
CMPX
Cautious Hold Rating for Compass Therapeutics Amid Clinical and Regulatory Uncertainties
PremiumRatings
Cautious Hold Rating for Compass Therapeutics Amid Clinical and Regulatory Uncertainties
1M ago
CMPX
Compass Therapeutics Reports 2024 Financial Results
PremiumCompany Announcements
Compass Therapeutics Reports 2024 Financial Results
1M ago
CMPX
Compass Therapeutics reports Q4 EPS (11c), consensus (9c)
PremiumThe Fly
Compass Therapeutics reports Q4 EPS (11c), consensus (9c)
1M ago
CMPX
Compass Therapeutics sees cash runway into 1Q27
PremiumThe Fly
Compass Therapeutics sees cash runway into 1Q27
1M ago
CMPX
Compass Therapeutics initiated with a Buy at Guggenheim ahead of BTC data
PremiumThe FlyCompass Therapeutics initiated with a Buy at Guggenheim ahead of BTC data
1M ago
CMPX
Compass Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Compass Therapeutics initiated with a Buy at Guggenheim
1M ago
CMPX
Compass Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Compass Therapeutics initiated with an Overweight at Piper Sandler
2M ago
CMPX
Buy Rating for Compass Therapeutics Driven by Promising Tovecimig Results and Strategic Pipeline
PremiumRatings
Buy Rating for Compass Therapeutics Driven by Promising Tovecimig Results and Strategic Pipeline
2M ago
CMPX
Two new option listings on February 11th
PremiumThe Fly
Two new option listings on February 11th
2M ago
AZ
CMPX
Optimistic Buy Rating for Compass Therapeutics Due to Promising CTX-009 Trial Results and Market Potential
PremiumRatings
Optimistic Buy Rating for Compass Therapeutics Due to Promising CTX-009 Trial Results and Market Potential
2M ago
CMPX
Compass Therapeutics price target raised to $8 from $7 at Jefferies
PremiumThe Fly
Compass Therapeutics price target raised to $8 from $7 at Jefferies
2M ago
CMPX
Compass Therapeutics provides corporate update, CTX-009 advances
PremiumThe FlyCompass Therapeutics provides corporate update, CTX-009 advances
3M ago
CMPX
Compass Therapeutics initiated with a Buy at D. Boral Capital
Premium
The Fly
Compass Therapeutics initiated with a Buy at D. Boral Capital
4M ago
CMPX
Compass Therapeutics Appoints New CFO Amid Strategic Moves
Premium
Company Announcements
Compass Therapeutics Appoints New CFO Amid Strategic Moves
4M ago
8K
CMPX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >